Optimization of retroviral gene transfer protocol to maintain the lymphoid potential of progenitor cellsHACEIN-BEY, Salima; GROSS, Fabian; NUSBAUM, Patrick et al.Human gene therapy. 2001, Vol 12, Num 3, pp 291-301, issn 1043-0342Article

Gene therapy of severe combined immunodeficienciesFISCHER, Alain; HACEIN-BEY, Salima; LE DEIST, Francoise et al.Immunological reviews. 2000, Vol 178, pp 13-20, issn 0105-2896Article

Adenovirally transduced dendritic cells induce bispecific cytotoxic T lymphocyte responses against adenovirus and cytomegalovirus pp65 or against adenovirus and Epstein-Barr virus EBNA3C protein: A novel approach for immunotherapyHAMEL, Yamina; BLAKE, Neil; CAVAZZANA-CALVO, Marina et al.Human gene therapy. 2002, Vol 13, Num 7, pp 855-866, issn 1043-0342Article

Thérapie génique des déficits immunitaires. Discussion = Gene therapy of immunodeficiency disorders. DiscussionFISCHER, Alain; HACEIN-BEY, Salima; KAPLAN, Jean-Claude et al.Bulletin de l'Académie nationale de médecine. 2000, Vol 184, Num 7, pp 1417-1430, issn 0001-4079Conference Paper

Greffe de moelle osseuse T déplétée HLA non géno-identique chez l'enfant: prévention de la réaction du greffon contre l'hôte par adjonction de lymphocytes T du donneur dépourvus d'alloréactivité vis-à-vis du receveur = Donor T lymphocytes infusion following ex vivo depletion of donor anti-host reactivity by a specific anti-interleukin-2 receptor p55 chain immunotoxin. Preliminary results of a phase I/II trialCAVAZZANA-CALVO, Marina; ANDRE-SCHMUTZ, Isabelle; BUFFET, Renaud et al.Journal de la Société de biologie. 2001, Vol 195, Num 1, pp 65-68, issn 1295-0661Conference Paper